The Patent Finder

Zafgen, Inc.

Also on record
Records under this name other than patents Zafgen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Zafgen, Inc.

PatentTitleStatus Expires Confidence
US 9,260,419Polymorphic salt of a metap-2 inhibitor and methods of making and using same
Lapsed on the fee record
Ended Feb 16, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 16, 2024From the USPTO record
US 9,221,787Sulphonamine compounds and methods of making and using same
Lapsed on the fee record
Ended Dec 29, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 29, 2023From the USPTO record
US 9,187,494Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators
Lapsed on the fee record
Ended Nov 17, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 17, 2023From the USPTO record
US 9,173,865Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol
Lapsed on the fee record
Ended Nov 3, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 3, 2023From the USPTO record
US 10,406,134Methods of Treating an Overweight Subject
Formerly held
Lapsed on the fee record
Ended Sep 10, 2023 · Medium confidence
Lapsed on the fee recordEnded Sep 10, 2023Medium confidence
US 9,067,905Sulphone compounds and methods of making and using same
Lapsed on the fee record
Ended Jun 30, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jun 30, 2023From the USPTO record
US 9,067,913Fumigillol type compounds and methods of making and using same
Lapsed on the fee record
Ended Jun 30, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jun 30, 2023From the USPTO record
US 10,259,796Oxaspiro[2.5]octane derivatives and analogs
Lapsed on the fee record
Ended Apr 16, 2023 · From the USPTO record
Lapsed on the fee recordEnded Apr 16, 2023From the USPTO record
US 9,000,035Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol
Lapsed on the fee record
Ended Apr 7, 2023 · From the USPTO record
Lapsed on the fee recordEnded Apr 7, 2023From the USPTO record
US 10,231,946Methods of treating ischemic organ damage and other disorders
Lapsed on the fee record
Ended Mar 19, 2023 · From the USPTO record
Lapsed on the fee recordEnded Mar 19, 2023From the USPTO record
10 of 48 patents shown.
Pro members see all 48.
Pro members: see all 48 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited